"Hereditary Hematologic Malignancies: Not That Rare" - Webinars and Q&A Sessions

Dr. Courtney D. DiNardo of the University of Texas MD Anderson Cancer Center presents on the following learning objectives:
• Understanding the role of genetic testing on patient outcomes for HM patients
• Learning the prevalence of pathogenic germline variants in HM patients
• Gaining tools on how to suspect and diagnose hereditary HM
• How to manage hereditary HM patients and their at-risk family
This webinar took place on May 23rd and May 25th, 2022, and both of the Q&A sessions with expert panelists held after each presentation are included in this video:
May 23rd
Dr. Amy DeZern: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Dr. Michael Savona: Vanderbilt-Ingram Cancer Center. Vanderbilt University School of Medicine
May 25th
Dr. Yasmin Abaza: Northwestern University, Feinberg School of Medicine
Dr. Kelly Bolton: Washington University School of Medicine
Dr. Elizabeth Griffiths: Roswell Park Comprehensive Cancer Center, SUNY at Buffalo
This event is intended for health care professionals who care for patients with hematologic malignancies.